Abstract:Background: Little is known about the true prevalence and clinical characteristics of movement disorders in early multiple sclerosis (MS) and related demyelinating diseases. We conducted a prospective study to fill this knowledge gap. Methods: A consecutive patient sample was recruited from the MS clinic within a 1-year-period. Patients diagnosed over 5 years before the study start date were excluded. Each eligible patient was interviewed by a movement disorder neurologist who conducted a standardized movement disorder survey and a focused examination. Each patient was followed prospectively for 1-4 follow-up visits. Movement disorders identified on examination were video-recorded and videos were independently rated by a separate blinded movement expert. Results: Sixty patients were included (56.6% female, mean age 38.3 ± 12.7 years). Eighty percent reported one or more movement disorders on the survey and 38.3% had positive findings on examination. After excluding incidental movement disorders (e.g., essential tremor), 58.3% were thought to have demyelination-related movement disorders. The most common movement disorders in a descending order were restless legs syndrome, tremor, tonic spasms, myoclonus, focal dystonia, spontaneous clonus, fasciculations, pseudoathetosis, hyperekplexia, and hemifacial spasm. The movement disorder started 5 months following a relapse on average but in 8 patients it was the presenting symptom of a new relapse or the disease itself. The majority of movement disorders occurred secondary to spinal (85.7%) or cerebellar/brainstem lesions (34.2%). Spinal cord demyelination was the only statistically significant predictor of demyelination-related movement disorders. Conclusion: Movement disorders are more common than previously thought even in early MS. They typically begin a few months after spinal or brainstem/cerebellar relapses but may occasionally be the presenting symptom of a relapse.

Movement Disorders in Multiple Sclerosis: An Update

Mirror Movements In Acquired Neurological Disorders: A Mini-Review

Movement disorders in early MS and related diseases: A prospective observational study

Movement Disorders in Patients with Subacute Sclerosing Panencephalitis: A Systematic Review

Peripherally-induced Movement Disorders: An Update

Post-stroke Movement Disorders: Clinical Spectrum, Pathogenesis, and Management

Behavioral disorders in multiple sclerosis: a comprehensive review

Psychogenic movement disorders

Rethinking Movement Disorders

Relationship between COVID-19 and movement disorders: A narrative review

Eye Movement Abnormalities in Multiple Sclerosis: Pathogenesis, Modeling, and Treatment

Multimodal neuroimaging to characterize symptom-specific networks in movement disorders

Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic Approaches

Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action

Current challenges in the pathophysiology, diagnosis, and treatment of paroxysmal movement disorders

Spinal movement disorders in NMOSD, MOGAD, and idiopathic transverse myelitis: a prospective observational study

Hyperkinetic and Hypokinetic Movement Disorders in SSPE: A Systematic Review of Case Reports and Case Series

Paroxysmal movement disorders

Current and emerging therapies in multiple sclerosis: a systematic review

Multiple System Atrophy: Advances in Diagnosis and Therapy

Cocaine-induced Movement Disorder: A Literature Review